CS Paper Radar

Evaluating Type-1 Diabetes Digital Twins by Decision Quality

Victor Li, Owen Tucker, Michael S. Hughes, Temiloluwa Prioleau, Shengpu Tang

cs.LG ·submitted 2026-10-22 01:14 UTC · v1
code/data

Abstract

A digital twin (DT) for type 1 diabetes (T1D) can predict how an individual's blood glucose will respond to different insulin treatments without actually trying them. For each treatment, downstream statistics of predicted glucose trajectories, such as glycemic risk, can be computed to guide clinical decisions. However, the quality of DTs is usually measured by the accuracy of their predicted glucose trajectories, which may not reflect the quality of the downstream treatment decisions they inform. In this work, we directly evaluate DTs by this decision quality on downstream treatment ranking, i.e., whether a DT predicts glucose trajectories that can be used to rank candidate treatments as the real patient would. We present an evaluation protocol over 30 virtual patients from the FDA-accepted UVA/Padova model, each simulated under 21 different basal-bolus treatments. For each patient, a DT is fitted under one treatment and then produces glucose trajectories for the remaining 20 treatments. Our results show that prediction accuracy and decision quality disagree. A baseline that models the average patient, never seeing the individual's glucose data, has the lowest prediction accuracy of all six methods (RMSE: 63.6 mg/dL) but ranks treatments with the second-highest mean Spearman (0.766), while a black-box neural network that predicts glucose nearly twice as accurately (RMSE: 32.9 mg/dL) ranks them no better than a random ordering of the 20 treatments (0.049 Spearman). Therefore, selecting a DT based on prediction accuracy alone can prefer one that recommends treatments at chance, and decision quality must be evaluated directly rather than assumed to follow from prediction accuracy.

Comment
12 pages, 1 figure, 7 tables. Code: https://github.com/Veeeeeee7/T1D-Digital-Twin-Benchmark

Closest papers

Nearest neighbours by meaning across the whole index.

Sensitivity-driven Personalization of a Glucoregulatory Model for Digital Twin Therapeutics in Type 1 Diabetes

eess.SY ·2026-09-25 ·Clara Escorihuela-Altaba, Vihangkumar V. Naik, Eleonora Manzoni, Jose Garcia-Tirado
similarity 0.67
Abstract

Digital twins are increasingly used in diabetes research, but reproducing individual glucose dynamics requires accurate identification of glucoregulatory model parameters. Traditional sensitivity analysis can identify influential parameters, yet a ranking based on limited conditions may miss parameters that matter during specific disturbances or for particular individuals. We therefore examine both the magnitude and timing of parameter influence across dynamic input-output conditions and assess whether a common ranking holds across participants. We analyze the Hovorka glucoregulatory model using data from 192 participants receiving automated insulin delivery therapy in the Type 1 Diabetes and Exercise Initiative dataset. We extend Sobol sensitivity analysis to time series and rank parameter influence under four conditions: full-day profiles, isolated meal disturbances, insulin bolus injections, and postprandial responses. We combine the condition-specific results into a global ranking and use it to select parameters for participant-specific identification. Compared with population parameters, identification restricted to the sensitivity-derived subset reduces the root mean square error of 60-minute glucose predictions by 60%, to approximately 31 mg/dL. These findings suggest that a global ranking can capture parameter influence across individuals and dynamic conditions. By narrowing the parameters requiring identification, this approach reduces computational cost and could accelerate the development of personalized diabetes digital twins.

0.20

Reliability-Aware Short-Term Glycemic Risk Prediction Using an Anchor-Based Comparative Framework of Sequence, Multimodal, and State-Updating Digital-Twin Models

cs.LG cs.AI ·2026-10-26 ·Pir Bakhsh Khokhar, Carmine Gravino, Fabio Palomba
similarity 0.65
Abstract · 36 pages, including figures, tables, and references. Research article on reliability-aware glycemic-risk prediction using sequence models an…

Anticipating short-term hypoglycemic and hyperglycemic risk is essential for proactive diabetes management. However, existing machine learning approaches often use inconsistent evaluation protocols and emphasize predictive performance over reliability. This study introduces an anchor-based benchmarking framework integrating longitudinal glucose sequences and multimodal patient information. Using the T1DiabetesGranada dataset, 5,503,441 standardized prediction anchors were constructed from 736 individuals with type 1 diabetes to evaluate hypoglycemia and hyperglycemia prediction at 30-, 60-, and 120-minute horizons. Three neural architectures, a Hybrid LSTM-Transformer, a Multimodal Digital Twin, and a State-Updating Digital Twin with gap-aware longitudinal state progression, were compared under identical patient-level validation protocols. Beyond predictive performance, the evaluation examined calibration, classification thresholds, explanation reliability, cross-model disagreement, and robustness to controlled perturbations. No statistically significant predictive differences were observed after Holm correction, although the models exhibited complementary reliability characteristics. The Multimodal Digital Twin achieved the lowest mean Brier score, while the State-Updating Digital Twin demonstrated the lowest mean expected calibration error (ECE-10). The Hybrid LSTM-Transformer showed strong explanation faithfulness and stability under its temporal attribution protocol. These findings highlight the importance of evaluating digital-twin models beyond predictive accuracy and emphasize the need for reliability assessment and external validation before clinical deployment.

0.24

FairGlucose: A CGM Fairness Benchmark Reveals Subgroup Disparities Hidden in Population-Level Validation

cs.CY cs.AI ·2026-08-18 ·Junjie Luo, Xuzhe Zhi, Rui Han, Abhimanyu Kumbara, Anand K. Iyer +3 more
benchmark similarity 0.61
Abstract

As CGM-based AI tools approach clinical deployment, whether their accuracy is equitable across patient demographics remains insufficiently tested. To enable this evaluation, we constructed FairGlucose, a 300-patient CGM cohort balanced across 12 demographic strata (age x gender x type 1/type 2 diabetes), with 132,480 forecasting samples and 3,945 unique behavioral events (meals, exercise, medication) logged by 81 patients. Benchmarking 33 models across four families on 2-hour glucose forecasting, we find that population-level external validation can conceal substantial subgroup disparities. Aggregate out-of-distribution metrics appear stable (approximately 1.0), yet subgroup-level ratios range from 0.8 to 1.4, with T1D patients showing 6 mg/dL higher prediction error than T2D (p < 0.001). This disparity persists across all 33 models, suggesting a property of the prediction task rather than any single architecture. Further analysis shows that subgroup performance gaps align with the proportion of clinically hard cases, and that input-length sensitivity varies across demographics, motivating personalized configurations. Frontier LLMs underperform specialized neural models by 1-6 mg/dL; behavioral events contribute negligibly (approximately 0.1 mg/dL) even under oracle event access. These findings establish that population-level validation alone is insufficient for equity assessment of digital health AI, motivating subgroup-disaggregated reporting as a default standard.

0.29

Agentic LLM reasoning in pediatric diabetes outcome prediction from multimodal medical records

cs.CL q-bio.QM ·2026-10-29 ·Daniel Palacios, Guantong Qi, Anna Kadi, Natali Borrego, Sukru Aras +6 more
similarity 0.58
Abstract · 18 pages main text plus 40 pages Supplementary Information

Large language model (LLM) agents are proposed for clinical prediction but are untested in pediatrics, where cohorts are small and outcomes are uncommon. Using records from 2,489 youth with type 2 diabetes (T2D) and 4,018 with type 1 diabetes (T1D), spanning structured data, note-derived social determinants and, in T1D, continuous glucose monitoring data, we predicted seven T2D outcomes, four also in T1D, at 24 months from 18 months of follow-up. CEDAR (Clinical Evidence-Driven Agent for Risk-prediction), an evidence-citing, self-auditing LLM pipeline, outperformed trained machine learning in both cohorts (pooled area under the receiver operating characteristic curve 0.815 versus 0.656 to 0.700 in T2D and 0.756 versus 0.603 to 0.631 in T1D), most on the sparsely screened outcomes. Only 4 of 70,246 values it cited did not match the chart. Reading only the evidence and reasoning cited by CEDAR, two pediatric endocrinologists reached the same prediction as CEDAR in about nine of ten cases, agreeing with each other on 90.5%.

0.31

Intervention-Conditioned Counterfactual Human Digital Twin Generator

cs.LG q-bio.QM ·2026-10-09 ·Saeed Farzi, Sofia Michopoulou, Christopher Kipps, Rahman Attar
similarity 0.55
Abstract

Chronic diseases evolve through long, heterogeneous trajectories shaped by interacting mediators, confounders, and treatment histories. Estimating long-term patient trajectories under alternative interventions is essential for in silico clinical trial design. However, most existing models overlook irregular visit intervals and cross-mediator dependencies, both of which are crucial for reliable long-term longitudinal prediction. Moreover, these models typically focus on outcome prediction rather than generating complete patient-state trajectories. To address these challenges, we propose CHDT, an intervention-conditioned Human Digital Twin generator under standard identification assumptions for multimodal longitudinal trajectory estimation. Its main empirical advantage arises from explicit modeling of irregular visit intervals, while cross-mediator refinement provides additional gains in selected intervention-conditioned settings. Across real-world ADNI and simulator-generated ALPACA cohorts, CHDT shows improved long-horizon patient-state fidelity relative to competing baselines. Ablation results indicate that irregular-time conditioning provides the primary empirical gain, and cross-mediator refinement provides additional improvements.

0.11

MedJev: Evaluating Zero-Shot System-One Decision Making in Medicine

cs.CL cs.AIcs.LG ·2026-10-26 ·Simon A. Lee, Jiahang Sha, Moonseong Jeong, Yunbei Pan, Jeffrey N. Chiang
similarity 0.55
Abstract

System One decision models such as Jev answer structured questions in a single forward pass without generating text, offering fast and computationally efficient clinical decision support. We evaluate MedJev, an open System One model that runs locally on a laptop, across ten medical benchmarks spanning medical knowledge, diagnosis, and patient level prediction using MIMIC IV and MIMIC IV ED. We compare MedJev against zero shot LLM baselines, published GPT results, and supervised models. MedJev achieves accuracies of 72.5 percent on MedQA, 75.4 percent on USMLE, and 80.1 percent on NEJM, approaching published GPT 4 performance while maintaining well calibrated confidence estimates (ECE 0.028 to 0.063). On patient level tasks, MedJev achieves an AUROC of 0.926 for In Hospital Mortality, exceeding XGBoost (0.902), but underperforms supervised models on operational outcomes such as ED Triage Admission (0.745 vs. 0.809). Patient level predictions also exhibit substantial miscalibration (In Hospital Mortality ECE 0.286). We introduce a lightweight, two parameter recalibration method that adapts predictions to local patient populations using 50 to 200 labeled examples, reducing ECE to 0.007. Our findings establish open System One models as a promising zero shot baseline for medical AI, combining competitive predictive performance with low computational cost and efficient local calibration. We release our code and evaluation harness to support future research.

0.24

It's All in the Way You Say It: The Role of Information Representation in LLM-Based Glycemic-Event Prediction

cs.AI ·2026-09-08 ·Andrea Apicella, Pasquale Arpaia, Matteo Orefice, Andrea Pollastro, Roberto Prevete
similarity 0.55
Abstract · Submitted to a journal for peer-review

Large Language Models (LLMs) are increasingly being investigated for physiological time-series prediction, yet their effectiveness may depend not only on the model itself, but also on how physiological information is represented and presented at inference time. This study investigates prompt-based general-purpose LLMs for postprandial hyperglycemia and hypoglycemia prediction in individuals with type 1 diabetes. Using the OhioT1DM dataset, we evaluate multiple open-weight LLMs under zero-shot and few-shot inference across prediction horizons of 30, 60, and 90 minutes. The analysis varies both the textual representation of the available physiological information and the amount of information exposed to the model, ranging from glucose observations alone to derived descriptors and additional contextual variables related to insulin, meals, carbohydrates, and physical activity. Performance is compared with conventional patient-specific supervised models and with Gluco-LLM, a language-model-based architecture explicitly adapted to glucose time-series forecasting. Results show a marked task-dependent behavior. Conventional supervised models achieve the strongest performance for hyperglycemia prediction, whereas the best observed prompt-based LLM configurations improve performance for hypoglycemia across all investigated horizons. The effectiveness of prompt-based inference is also strongly influenced by how physiological information is represented, while providing additional contextual information does not lead to a systematic improvement. Overall, these findings highlight physiological information representation as a central design factor in prompt-based LLM approaches to glycemic-event prediction.

0.35

DIASENTINEL: An Auditable Multi-Agent System for Guideline-Grounded Diabetes Risk Screening

cs.CL ·2026-08-31 ·Yung Wei Shueh, Zhi-Jie Chen, Chia-Hsuan Hsu, Hsin-Ling Hsu, Donghua Zhang +7 more
top venue similarity 0.55
Abstract

Large language models (LLMs) offer promising clinical decision support but remain vulnerable to hallucinated facts, unsupported recommendations, and citation errors. We present DIASENTINEL, a fully on-premise multi-agent system for one-year type 2 diabetes mellitus (T2DM) risk screening and guideline-grounded report generation from electronic health records (EHRs). The system integrates calibrated risk prediction, deterministic clinical signal extraction, Reciprocal Rank Fusion over American Diabetes Association (ADA) guidelines, and a hybrid verification layer combining rule-based checks with LLM entailment. The demonstration provides a real-time batch-screening dashboard and an interactive patient report interface with cited recommendations, verification results, and raw EHR comparison. DIASENTINEL demonstrates a practical framework for reliable, auditable, and privacy-preserving LLM-based clinical decision support.

0.33